Aurora to buy MedReleaf for $2.5 billion in pot mega-merger
Aurora Cannabis will buy rival MedReleaf for C$3.2 billion ($2.51 billion), the companies said on Monday, the biggest deal [...more]
Read ArticleSVP I, the debut fund for the firm, closed in December 2002 and invested with four highly successful leveraged buyout funds. SVP I is diversified by sector and geography.
Learn MoreSVP II is a leveraged buyout fund of funds which closed in December 2006. SVP II represents a continuation of the successful strategy utilized by the predecessor fund, primarily investing with large, top tier LBO and growth equity firms. SVP II is diversified by sector and geography.
Learn MoreSVP Real Estate I, LP ("SVP RE I"), closed in February 2008, is a private real estate fund of funds. As with SVP I & II, SVP RE I received allocations with historically successful, highly sought after underlying fund managers who pursue compelling investment strategies. The fund is diversified by sector (Office, Hotel, Industrial/Warehouse, Retail and Residential) and geography (U.S., Europe, and Asia/Pacific).
Learn MoreThe GHP Credit Opportunity Fund (“GHP COF”) is a fund of alternative credit and distressed debt funds that is being raised and invested to pursue two specific investment themes: (1) the de-leveraging of European Banks, and (2) the potential for a distressed cycle in U.S. High Yield Credit. GHP COF will pursue complex liquid and illiquid credit opportunities in the U.S. and Europe.
Learn MoreAurora Cannabis will buy rival MedReleaf for C$3.2 billion ($2.51 billion), the companies said on Monday, the biggest deal [...more]
Read ArticleIn the weed world, Big Pharma is typically seen as an enemy. It’s the industry that [...more]
Read ArticleCOLUMBUS, OHIO Human error led to a company’s inadvertent exclusion from the proposed list of the [...more]
Read ArticleIt’s the first marijuana unicorn in the country. California basedMedMen recently received a $30 million investment from [...more]
Read ArticleIndica Industries Pty Ltd, the partner of Canadian licensed producer MedReleaf (TSX: LEAF) (OTC: MEDFF) that [...more]
Read ArticleToronto, Ontario–(Newsfile Corp. – January 30, 2018) – RISE Research Inc. (“RISE”) and Luminor Medical Technologies [...more]
Read Article